European Archives - Page 91 of 1659 - European Medical Journal

Sex Differences Highlight Distinct Patterns in Glomerular Diseases

A nationwide biopsy analysis identified persistent sex differences in glomerular diseases, including variation in clinical presentation, age distribution and renal function.

Workload Differences Using the Senhance System for RARP

Numerous scientific papers have examined improved patient outcomes associated with robotic surgery, especially regarding shorter hospital…

Gut and Seminal Microbiomes May Influence Reproductive Outcomes

Gut dysbiosis in women and seminal microbiome changes in men may be linked to poorer reproductive outcomes, a new study suggests.

Person having ECG

ECG Fatigue Detection Model Improves Elderly Monitoring

Learn how machine learning ECG fatigue detection achieved 97.96% accuracy in older adults using a machine learning model.

Someone taking blood sugar

Amylyx successful phase 3 trials for blood sugar drug

Amylyx’s avexitide cut hypoglycemic episodes by 55% in a phase 3 trial for post-bariatric hypoglycemia.

UK Low Emissions Policy Improved Children’s Lung Health

New study shows children’s lung growth rebounded after London introduced its Ultra Low Emission Zone in 2019.

BMI scale

Higher BMI Reduces Effectiveness of JAK Inhibitors in Arthritis

A large meta-analysis found higher BMI significantly reduces JAK inhibitor effectiveness in rheumatoid arthritis, especially at higher obesity classes.

A broken ladder, with a hand holding the missing piece

Why great therapies still fail to reach patients

A breakthrough in the lab does not guarantee a breakthrough for patients. So what gets in the way between approval and access?

Person pointing to a model of the colorectal system

Tislelizumab Boosts Tumour Response in Pre-Surgery Rectal Cancer

Adding tislelizumab to radiotherapy and chemotherapy boosted major tumour regression in locally advanced rectal cancer before surgery in a phase II trial.

Network Analysis of the Serum Proteome in ICI Recipients Highlights IFN-γ As A Pivotal Mediator of irAE

Immune checkpoint inhibitors (ICI) have transformed cancer therapy but carry a significant risk of immune-related adverse…